Latin American Next-Gen Sequencing Market Sees Multi-Faceted Development

Latin American Next-Gen Sequencing Market Sees Multi-Faceted Development

The government of Brazil was an early proponent of genome research and at one point had accomplished one-third of all human DNA sequencing. Originally led by a British geneticist who has since sought to spark similar research in other emerging regions (South Africa, China, Russia), Brazilian sequencing activities have proliferated along various lines of research and represent the core of regional Latin American demand for next-sequencing platforms. Kalorama Information recently profiled the Latin American next-generation sequencing market through a survey of institutions in Brazil as well as Mexico, Chile, Columbia, and other South and Central American and Caribbean countries.

Latin American sequencing is still largely associated with academia; universities are primarily responsible for the recruitment and training of qualified personnel in genome research and the incubation diagnostic and therapeutic technologies as well as applied life science products. The Human Genome and Stem Cell Research Center (HUG-CELL) at the University of São Paulo has followed its original research into the human genome with additional genome mapping of indigenous human populations, agricultural pests, and crops in Brazil. Crucially, HUG-CELL - in partnership with the São Paulo Research Foundation - has also supported the development of commercial start-ups such as Mendelics and Genius. Mendelics provides specialized exome sequencing services for patient healthcare and has the highest sequencing capacity in the country. Genius will develop molecular test kits through its specialty in cellular reprogramming.

Brazilian next-generation sequencing capacity is hoped to power the development of molecular test kits diagnosing autism and other brain functioning disorders. Ethnic variation in Brazil is also anticipated to present unique opportunities to develop sequencing-derived diagnostics and treatments for rare diseases.

For more information regarding installed bases of next-generation sequencers in Latin America, sequencer distribution by application areas, and vendor market shares, please consult Kalorama Information’s Next-Generation Sequencing in Latin America.